SightfileU.S. market data from official filings

Companies › INTS

INTENSITY THERAPEUTICS INC (INTS)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001567264 · EDGAR filings · Updated 2026-07-20

INTENSITY THERAPEUTICS INC (INTS) has reported institutional ownership of 5.6%, with 12 institutional managers holding positions valued at $829.5K per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership
5.6%
Institutional managers
12
Reported 13F value
$829.5K
Insider activity
5 trans.
$0 net flat
Data flags
2 active
from SEC filings

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, INTENSITY THERAPEUTICS INC has 12 institutional holders and institutional ownership of 5.6%.

Insider activity

Insiders reported 5 transactions (0 buys, 0 sells) across 3 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-07 (recurring since 2024-03-14) — source filing. The authoritative details are those stated in the filing itself.
Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2025-12-05 (recurring since 2024-04-19) — source filing. The authoritative details are those stated in the filing itself.

Related companies

BULLFROG AI HLDGS INC (BFRG) · Tempest Therapeutics Inc (TPST) · BioCardia Inc (BCDA) · Phio Pharmaceuticals Corp (PHIO) · CELLECTAR BIOSCIENCES INC (CLRB) · ABVC BIOPHARMA INC (ABVC)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-20.